SavedAdd your journal

Journals / Erciyes Medical Journal / 2022 / Cilt: 44 - Sayı: 4

Assessment of P Wave Peak Time and P Wave Dispersion in Patients with COVID-19 Infection

Şaban KELEŞOĞLU
Deniz ELÇİK
Pages
375–381
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: It was determined that the Pmax and PD values of the patients infected with the COVID-19 virus were higher than the control group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aims to evaluate P wave distribution (PD) and P wave peak time (PWPT) in COVID-19 patients.
📊
Key Findings & Data:Materials and Methods: A total of 140 participants were recruited in our study.
💡
Conclusion & Impact:Results: It was determined that the Pmax and PD values of the patients infected with the COVID-19 virus were higher than the control group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aims to evaluate P wave distribution (PD) and P wave peak time (PWPT) in COVID-19 patients. Materials and Methods: A total of 140 participants were recruited in our study. The COVID-19 group included 74 subjects, and the control group included 66 individuals. Between the two groups, PD was compared for electrocardiographic P-wave measurements, including abnormal P wave axis, P wave terminal force in V1 (PWTF), P wave max duration (Pmax), and PWPT. Results: It was determined that the Pmax and PD values of the patients infected with the COVID-19 virus were higher than the control group (p

🔖

Cite This Article

KELEŞOĞLU, Ş., ELÇİK, D. (2022). Assessment of P Wave Peak Time and P Wave Dispersion in Patients with COVID-19 Infection. Erciyes Medical Journal, Cilt: 44 - Sayı: 4, 375–381. https://ajindex.com/articles/502152

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020; 116(10): 1666–87
  2. Kelesoglu S, Yilmaz Y, Ozkan E, Calapkorur B, Gok M, Dursun ZB, et al. New onset atrial fibrilation and risk faktors in COVID-19. J Electrocardiol 2021; 65: 76–81
  3. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130(23): 2071–104. Erratum in: Circulation 2014; 130(23): e270–1
  4. Miller JD, Aronis KN, Chrispin J, Patil KD, Marine JE, Martin SS, et al. Obesity, exercise, obstructive sleep apnea, and modifiable atherosclerotic cardiovascular disease risk factors in atrial fibrillation. J Am Coll Cardiol 2015; 66(25): 2899–906
  5. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006; 27(2): 136–49
  6. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 2007; 50(21): 2021–8
  7. Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J 2020; 41(19): 1798–800
  8. De Flora S, Balansky R, La Maestra S. Rationale for the use of Nacetylcysteine in both prevention and adjuvant therapy of COVID-19. FASEB J 2020; 34(10): 13185–93
  9. Çağdaş M, Karakoyun S, Rencüzoğulları İ, Karabağ Y, Yesin M, Gürsoy MO, et al. P wave peak time; a novel electrocardiographic parameter in the assessment of coronary no-reflow. J Electrocardiol 2017; 50(5): 584–90
  10. Yıldırım E, Günay N, Bayam E, Keskin M, Ozturkeri B, Selcuk M. Relationship between paroxysmal atrial fibrillation and a novel electrocardiographic parameter P wave peak time. J Electrocardiol 2019; 57: 81–6
  11. Tükek T, Akkaya V, Demirel S, Sözen AB, Kudat H, Atilgan D, et al. Effect of Valsalva maneuver on surface electrocardiographic P-wave dispersion in paroxysmal atrial fibrillation. Am J Cardiol 2000; 85(7): 896–9, A10
  12. Kawano S, Hiraoka M, Sawanobori T. Electrocardiographic features of P waves from patients with transient atrial fibril